Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain
NCT: NCT06655844 · RECRUITING
Brief Summary
This study will investigate the effectiveness of the Sana Pain Reliever (Sana PR) at reducing chronic pain. The Sana PR is a device comprised of one main component (Mask with Earbuds) and two ancillary components (Charger and Headband). The device is worn over the eyes (with earbuds in ears). The device pulses light at a single wavelength but various frequencies throughout a specific firmware algorithm. Through the earbuds, the device also plays different tones in conjunction with the pulses. The device has a skin contacting Heart Rate Variability (HRV) sensor built into the forehead area that measures HRV throughout the use of the device. The system runs for 15 min at a time and is not FDA approved. The trial will last a total of 14 weeks. 50 participants who have a diagnosis of Post-treatment Lyme Disease and experience chronic pain are expected to take part in this study at Mount Sinai.
Frequently Asked Questions
What is Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain?
Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain is a clinical trial registered under NCT06655844. Current status: RECRUITING.
What is the status of NCT06655844?
The current status of NCT06655844 (Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain) is: RECRUITING.
When did Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain start?
Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain started on 2024-10-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.